Autonomic Manifestations in Parkinson's Disease
This course will cover assessing and managing autonomic dysfunction which is a common component to non-motor manifestations of Parkinson disease.
Jointly provided by Postgraduate Institute for Medicine and Parkinson & Movement Disorder Alliance
Release date: May 30, 2022
Expiration date: May 30, 2024
Estimated time to complete activity: 60 minutes
Target Audience
This course is for advanced practice professionals, neurologists, and other healthcare providers involved in the care of patients with a movement or related disorder.
After completing this activity, the participant should be better able to:
Kelly Papesh, DNP
Associate Director, APProvider Initiatives
Parkinson & Movement Disorder Alliance
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Kelly Papesh, DNP – Speakers Bureau: Amneal, Acorda Therapeutics, Abbvie
The PIM planners and others have nothing to disclose. The PMD Alliance planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PMD Alliance. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Learners should claim only the credit commensurate with the extent of their participation in the activity.
A smartphone, tablet, or computer with access to the internet.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
In order to obtain your CE certificate, please follow the directions provided at the conclusion of the course.
If you have questions regarding the certification of this activity, please contact PIM via email at [email protected] or PMD Alliance at [email protected]
Educational Objectives
Available CME Credit
Presentation: Autonomic Manifestations in Parkinson's Disease
Quiz: Autonomic Manifestations in Parkinson's Disease